Refill adherence to oral antihyperglycaemic drugs in Sweden

Acta Diabetologica

Volumn 46, Issue 3, 2009, Pages 203-208

  Haupt, Dan ^a   Weitoft, Gunilla Ringbäck ^b   Nilsson, J Lars G ^c  

^a LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

^b CENTRE FOR EPIDEMIOLOGY   (Sweden)

^c Network for Pharmacoepidemiology Foundation   (Sweden)

Author keywords

Adherence; Antihyperglycaemic drugs; Pharmacy records; Type 2 diabetes

Indexed keywords

ACARBOSE; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; METFORMIN; METFORMIN PLUS ROSIGLITAZONE; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SWEDEN; CLASSIFICATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PRESCRIPTION; STATISTICS;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DRUG PRESCRIPTIONS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SWEDEN;

EID: 69849090238     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-008-0076-1     Document Type: Article

References (29)

1. H King RE Aubert WH Herman 1998 Global burden of diabetes, 1995-2025-prevalence, numerical estimates, and projections Diabetes Care 21 9 1414 1431 9727886 10.2337/diacare.21.9.1414 1:STN:280:DyaK1czpsVyluw%3D%3D
2. AF Amos DJ McCarty P Zimmet 1997 The rising global burden of diabetes, its complications: estimates, projections to the year 2010 Diabet Med 14 12 S7 S85 10.1002/(SICI)1096-9136(199712)14:5+3.3.CO;2-I
3. International Diabetes Foundation. Diabetes e-atlas. http://www.eatlas. idf.org [Accessed 12.03.2008]
4. RC Turner RR Holman CA Cull, et al. 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 9131 837 853 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
5. RC Turner RR Holman IM Stratton CA Cull DR Matthews SE Manley V Frighi D Wright A Neil E Kohner H McElroy C Fox D Hadden 1998 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 9131 854 865 10.1016/S0140-6736(98) 07037-8 (Pubitemid 28416719)
6. Gudbjörnsdottir S, Cederholm J, Adamson U (2006) Nationella Diabetesregistret Årsrapport 2006 (The National Swedish Diabetes Registry)
7. JF Steiner AV Prochazka 1997 The assessment of refill compliance using pharmacy records: methods, validity, and applications J Clin Epidemiol 50 1 105 116 9048695 10.1016/S0895-4356(96)00268-5 1:STN:280:DyaK2s3gtVyltA%3D%3D (Pubitemid 27089212)
8. CA Jackevicius M Mamdani JV Tu 2002 Adherence with statin therapy in elderly patients with and without acute coronary syndromes Jama 288 4 462 467 12132976 10.1001/jama.288.4.462
9. L Wei J Wang P Thompson S Wong AD Struthers TM MacDonald 2002 Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study Heart 88 3 229 233 12181210 10.1136/heart.88.3.229 1:CAS:528:DC%2BD38XntFyrtbk%3D
10. BA Morningstar IS Sketris GC Kephart DA Sclar 2002 Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada J Clin Pharm Ther 27 3 213 220 12081636 10.1046/j.1365-2710.2002.00411.x 1:STN:280:DC%2BD38znsVWntQ%3D%3D (Pubitemid 34748147)
11. PT Donnan TM MacDonald AD Morris 2002 Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study Diabet Med 19 4 279 284 11942998 10.1046/j.1464-5491. 2002.00689.x 1:STN:280:DC%2BD383gvFertA%3D%3D (Pubitemid 34592152)
12. JA Spoelstra RP Stolk ER Heerdink OH Klungel JA Erkens HGM Leufkens DE Grobbee 2003 Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy? Pharmacoepidemiol Drug Saf 12 2 121 127 12642975 10.1002/pds.760 (Pubitemid 36304762)
13. SJ Kogut SE Andrade C Willey EP Larrat 2004 Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation) Pharmacoepidemiol Drug Saf 13 9 591 598 15362081 10.1002/pds.1005 (Pubitemid 39264221)
14. Anonymous. (2003) Adherence to long-term therapies. Evidence for action. World health organization
15. JA Cramer 2004 A systematic review of adherence with medications for diabetes Diabetes Care 27 5 1218 1224 15111553 10.2337/diacare.27.5.1218 (Pubitemid 38579798)
16. A Lindenmeyer H Hearnshaw E Vermeire P Van Royen J Wens Y Biot 2006 Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists J Clin Pharm Ther 31 5 409 419 16958818 10.1111/j.1365-2710.2006.00759.x 1:STN:280: DC%2BD28rjsV2msA%3D%3D (Pubitemid 44337289)
17. K Andersson A Melander C Svensson O Lind JL Nilsson 2005 Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication Eur J Public Health 15 6 621 626 16126746 10.1093/eurpub/cki053 (Pubitemid 41790247)
18. L Kindmalm A Melander JL Nilsson 2007 Refill adherence of antihyperglycaemic drugs related to glucose control (HbA(1c)) in patients with type 2 diabetes Acta Diabetol 44 209 213 17823765 10.1007/s00592-007-0006-7 1:CAS:528:DC%2BD2sXhtlSmu73I (Pubitemid 350132265)
19. B Wettermark N Hammar CM Fored A Leimanis P Otterblad Olausson U Bergman I Persson A Sundstrom B Westerholm M Rosen 2007 The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months Pharmacoepidemiol Drug Saf 16 7 726 735 16897791 10.1002/pds.1294 (Pubitemid 47180362)
20. Guidelines for ATC classification and DDD assignment (2006) World Health Organization
21. Statistics Sweden (SCB). http://www.scb.se. Accessed 4.02.2008
22. R Sikka F Xia RE Aubert 2005 Estimating medication persistency using administrative claims data Am J Manag Care 11 7 449 457 16044982
23. P Clarke A Gray A Adler R Stevens M Raikou C Cull I Stratton R Holman 2001 Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51) Diabetologia 44 3 298 304 11317659 10.1007/s001250051617 1:CAS:528: DC%2BD3MXhsFCmsr8%3D (Pubitemid 32234454)
24. A Gray M Raikou A McGuire P Fenn R Stevens C Cull I Stratton A Adler R Holman R Turner 2000 Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) Br Med J 320 7246 1373 1378 10.1136/bmj.320.7246. 1373 1:STN:280:DC%2BD3c3nvFyktg%3D%3D
25. KC Farmer 1999 Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice Clin Ther 21 6 1074 1090 10440628 10.1016/S0149-2918(99)80026-5 1:STN:280:DyaK1Mzmslansg%3D%3D discussion 1073 (Pubitemid 29326165)
26. AH Paes A Bakker CJ Soe-Agnie 1998 Measurement of patient compliance Pharm World Sci 20 2 73 77 9584340 10.1023/A:1008663215166 1:STN:280: DyaK1c3ksFeiuw%3D%3D (Pubitemid 28228437)
27. AM Butz M Donithan ME Bollinger C Rand RE Thompson 2005 Monitoring nebulizer use in children: comparison of electronic and asthma diary data Ann Allergy Asthma Immunol 94 3 360 365 15801247
28. K Krigsman JL Nilsson L Ring 2007 Adherence to multiple drug therapies: refill adherence to concomitant use of diabetes and asthma/COPD medication Pharmacoepidemiol Drug Saf 16 10 1120 1128 17566142 10.1002/pds.1433 (Pubitemid 350020065)
29. J Nilsson H Johansson M Wennberg 1995 Large differences between prescribed and dispensed medicines could indicate undertreatment Drug Inform J 29 1243 1246